Evaluation of a low-cost optical particle counter (Alphasense OPC-N2) for ambient air monitoring

A fast-growing area of research is the development of low-cost sensors for measuring air pollutants. The affordability and size of low-cost particle sensors makes them an attractive option for use in experiments requiring a number of instruments such as high-density spatial mapping. However, for these low-cost sensors to be useful for these types of studies their accuracy and precision need to be quantified. We evaluated the Alphasense OPC-N2, a promising low-cost miniature optical particle counter, for monitoring ambient airborne particles at typical urban background sites in the UK. The precision of the OPC-N2 was assessed by co-locating 14 instruments at a site to investigate the variation in measured concentrations. Comparison to two different reference optical particle counters as well as a TEOM-FDMS enabled the accuracy of the OPC-N2 to be evaluated. Comparison of the OPC-N2 to the reference optical instruments shows some limitations for measuring mass concentrations of PM1, PM2.5 and PM10. The OPC-N2 demonstrated a significant positive artefact in measured particle mass during times of high ambient RH (>85%) and a calibration factor was developed based upon °-Köhler theory, using average bulk particle aerosol hygroscopicity. Application of this RH correction factor resulted in the OPC-N2 measurements being within 33% of the TEOM-FDMS, comparable to the agreement between a reference optical particle counter and the TEOM-FDMS (20%). Inter-unit precision for the 14 OPC-N2 sensors of 22±13% for PM10 mass concentrations was observed. Overall, the OPC-N2 was found to accurately measure ambient airborne particle mass concentration provided they are (i) correctly calibrated and (ii) corrected for ambient RH. The level of precision demonstrated between multiple OPC-N2s suggests that they would be suitable devices for applications where the spatial variability in particle concentration was to be determined

Evolution of catalyst coated atomised magnesium spheres: an alternative thermal storage medium for concentrated solar power applications

Elevated temperature cycling studies were performed on two commercial gas atomised Mg spherical powders (average diameter of 26 μm and 30 μm) with magnetron sputtered catalysts (chromium, iron, vanadium and stainless steel) applied to their surfaces. At 350 °C, the presence of a catalyst promotes faster reaction kinetics with improving capacity until approaching stabilisation by the 90th cycle, e.g. the normalised capacity of V_Mg30 was found to rise from 45.5% to 65.5%. Following determination of activation energies (from Kissinger plots) and microstructural analysis of the post cycled structures a mechanism was proposed for the differing evolutions of the uncoated and coated Mg powders based upon a complex process in which particle sintering competes with particle fragmentation. Catalyst effectiveness varied with temperature, having a negligible impact on hydrogen storage characteristics of the atomised Mg powders following 50 cycles at 400 °C and this was mainly associated with the lack of multivalency in the catalysts

Opportunities for CO2 Storage around Scotland; An Integrated Strategic Research Study

Carbon Capture and Storage (CCS) is one of the critical technologies worldwide which will enable reduction of carbon dioxide (CO2) emissions arising from large industrial sites. CCS allows the continued use of a diverse mix of energy sources, including fossil fuels, which improves the security of cost-effective electricity supply. Scotland has the opportunity and responsibility to reduce CO2 emissions arising from burning of fossil fuels and their impact on climate change. The EU plans to have 12 CCS plants operating by 2015. In February 2009, the UK Secretary of State for Energy and Climate Change stated an aspiration for the UK to have more than one demonstration project in operation enabled by government funding. However, these targets cannot be delivered without the underpinning knowledge from studies such as this. Commitment to large-scale investment in CO2 capture plant will require proven storage capability. This study • presents the first high-level screening of CO2 storage sites available to Scotland • evaluates the means by which CO2 can be transported from power plants and other industrial activities to storage sites, and • investigates the costs and business constraints. This is the most comprehensive and fully integrated study performed in the UK, and was achieved by a collaborative partnership of Scottish Government, research universities and institutes, and a broad base of support from industry and business. The conclusions show that Scotland has an extremely large CO2 storage resource. This is overwhelmingly in offshore saline aquifers (deeply buried porous sandstones filled with salt water) together with a few specific depleted hydrocarbon fields. The resource can easily accommodate the industrial CO2 emissions from Scotland for the next 200 years. There is very likely to be sufficient storage to allow import of CO2 from NE England, this equating to over 25% of future UK large industry and power CO2 output. Preliminary indications are that Scotland's offshore CO2 storage capacity is very important on a European scale, comparable with that of offshore Norway, and greater than Netherlands, Denmark and Germany combined.Carbon Capture and Storage (CCS) is one of the critical technologies worldwide which will enable reduction of carbon dioxide (CO2) emissions arising from large industrial sites. CCS allows the continued use of a diverse mix of energy sources, including fossil fuels, which improves the security of cost-effective electricity supply. Scotland has the opportunity and responsibility to reduce CO2 emissions arising from burning of fossil fuels and their impact on climate change. The EU plans to have 12 CCS plants operating by 2015. In February 2009, the UK Secretary of State for Energy and Climate Change stated an aspiration for the UK to have more than one demonstration project in operation enabled by government funding. However, these targets cannot be delivered without the underpinning knowledge from studies such as this. Commitment to large-scale investment in CO2 capture plant will require proven storage capability. This study • presents the first high-level screening of CO2 storage sites available to Scotland • evaluates the means by which CO2 can be transported from power plants and other industrial activities to storage sites, and • investigates the costs and business constraints. This is the most comprehensive and fully integrated study performed in the UK, and was achieved by a collaborative partnership of Scottish Government, research universities and institutes, and a broad base of support from industry and business. The conclusions show that Scotland has an extremely large CO2 storage resource. This is overwhelmingly in offshore saline aquifers (deeply buried porous sandstones filled with salt water) together with a few specific depleted hydrocarbon fields. The resource can easily accommodate the industrial CO2 emissions from Scotland for the next 200 years. There is very likely to be sufficient storage to allow import of CO2 from NE England, this equating to over 25% of future UK large industry and power CO2 output. Preliminary indications are that Scotland's offshore CO2 storage capacity is very important on a European scale, comparable with that of offshore Norway, and greater than Netherlands, Denmark and Germany combined

Vernix caseosa peritonitis – no longer rare or innocent: a case series

<p>Abstract</p> <p>Introduction</p> <p>Vernix Caseosa peritonitis is a rare post caesarean section complication with only 19 case reports in the literature to date. Vernix caseosa spilt at the time of caesarean section is thought to incite an inflammatory reaction, causing symptoms resembling an acute abdomen.</p> <p>Case Presentation</p> <p>We discuss three Caucasian patients (aged 32 to 43 years) who presented in our health sector in Sydney with vernix caseosa peritonitis. Each had a protracted course with significant comorbidities requiring surgical and medical intervention. This contrasts with other reports suggesting that a rapid resolution can be expected.</p> <p>This cluster may be a consequence of the rising caesarean section rate, a heightened local awareness of the condition and possibly a result of leaving material in the paracolic gutters intraoperatively.</p> <p>Conclusion</p> <p>Our aim is to increase awareness among our obstetric and surgical colleagues of the characteristic clinical presentation and intra-operative findings of vernix caseosa peritonitis. We also point out that, in contrast to those presented here, not all patients require laparotomy.</p

Strategies to reduce antibiotic use in women with uncomplicated urinary tract infection in primary care: protocol of a systematic review and meta-analysis including individual patient data.

INTRODUCTION Uncomplicated urinary tract infection (UTI) in women is a common reason to present in general practice and is usually treated with antibiotics to reduce symptom severity and duration. Results of recent clinical trials indicate that non-antibiotic treatment approaches can also be effective. However, it remains unclear which patients would benefit from antibiotic treatment and which can effectively and safely be treated without antibiotics. This systematic review and meta-analysis aims to estimate the effect of treatment strategies to reduce antibiotic use in comparison with immediate antibiotic treatment and to identify prognostic factors and moderators of treatment effects. A further aim is to identify subgroups of patients benefiting from a specific therapy. METHODS AND ANALYSIS A systematic literature search will be performed to identify randomised controlled trials which investigated the effect of treatment strategies to reduce antibiotic use in female adults with uncomplicated UTI compared with immediate antibiotic treatment. Therefore, the primary outcome of the meta-analysis is incomplete recovery. Anonymised individual patient data (IPD) will be collected. Aggregate data will be used for pairwise comparisons of treatment strategies using meta-analysis models with random effects accounting for potential between-study heterogeneity. Potential effect moderators will be explored in meta-regressions. For IPD, generalised linear mixed models will be used, which may be adjusted for baseline characteristics. Interactions of baseline variables with treatment effects will be explored. These models will be used to assess direct comparisons of treatment, but might be extended to networks. ETHICS AND DISSEMINATION The local institutional review and ethics board judged the project a secondary analysis of existing anonymous data which meet the criteria for waiver of ethics review. Dissemination of the results will be via published scientific papers and presentations. Key messages will be promoted for example, via social media or press releases. PROSPERO REGISTRATION NUMBER CRD42019125804

Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults::a feasibility double-blind, placebo-controlled randomised trial

BACKGROUND: Pelargonium sidoides DC (Geraniaceae) root extract, EPs®7630 or "Kaloba®", is a widely used herbal remedy for respiratory infections, with some evidence of effectiveness for acute bronchitis. However, it is not yet widely recommended by medical professionals in the UK. There is a need to undertake appropriately designed randomised trials to test its use as an alternative to antibiotics. The aim was to assess the feasibility of conducting a double-blind randomised controlled trial of Pelargonium sidoides root extract for treatment of acute bronchitis in UK primary care, investigating intervention compliance, patient preference for dosage form and acceptability of patient diaries.STUDY DESIGN: Feasibility double-blind randomised placebo-controlled clinical trial.METHODS: We aimed to recruit 160 patients with cough (≤ 21 days) caused by acute bronchitis from UK general practices. Practices were cluster-randomised to liquid or tablet preparations and patients were individually randomised to Kaloba® or placebo. We followed participants up for 28 days through self-reported patient diaries with telephone support and reviewed medical records at one month. Outcomes included recruitment, withdrawal, safety, reconsultation and symptom diary completion rates. We also assessed treatment adherence, antibiotic prescribing and consumption, mean symptom severity (at days 2-4 after randomisation) and time to symptom resolution. We interviewed 29 patients and 11 health professionals to identify barriers and facilitators to running such a randomised trial.RESULTS: Of 543 patients screened, 261 were eligible, of whom 134 (51%) were recruited and 103 (77%) returned a completed diary. Overall, 41% (41/100) of patients took antibiotics (Kaloba® liquid group: 48% [15/31]; placebo liquid group: 23% [6/26]; Kaloba® tablet group: 48% [9/21]; placebo tablet group: 50% [11/22]). Most patients adhered to the study medication (median 19 out of 21 doses taken in week 1, IQR 18-21 - all arms combined). There were no serious adverse events relating to treatment. Most patients interviewed found study recruitment to be straightforward, but some found the diary too complex.CONCLUSIONS: It was feasible and acceptable to recruit patients from UK primary care to a double-blind placebo-controlled trial of herbal medicine (Kaloba®) for the treatment of acute bronchitis, with good retention and low data attrition.TRIAL REGISTRATION: HATRIC was registered on the ISRCTN registry ( ISRCTN17672884 ) on 16 August 2018, retrospectively registered. The record can be found at http://www.isrctn.com/ISRCTN17672884 .</p

Non-pharmaceutical interventions and risk of COVID-19 infection: survey of U.K. public from November 2020 – May 2021

Introduction: Non-pharmaceutical interventions (NPIs), such as handwashing, social distancing and face mask wearing, have been widely promoted to reduce the spread of COVID-19. This study aimed to explore the relationship between self-reported use of NPIs and COVID-19 infection. Methods: We conducted an online questionnaire study recruiting members of the UK public from November 2020 to May 2021. The association between self-reported COVID-19 illness and reported use of NPIs was explored using logistic regression and controlling for participant characteristics, month of questionnaire completion, and vaccine status. Participants: who had been exposed to COVID-19 in their household in the previous 2 weeks were excluded. Results: Twenty-seven thousand seven hundred fifty-eight participants were included and 2,814 (10.1%) reported having a COVID-19 infection. The odds of COVID-19 infection were reduced with use of a face covering in unadjusted (OR 0.17 (95% CI: 0.15 to 0.20) and adjusted (aOR 0.19, 95% CI 0.16 to 0.23) analyses. Social distancing (OR 0.27, 95% CI: 0.22 to 0.31; aOR 0.35, 95% CI 0.28 to 0.43) and handwashing when arriving home (OR 0.57, 95% CI 0.46 to 0.73; aOR 0.63, 95% CI: 0.48 to 0.83) also reduced the odds of COVID-19. Being in crowded places of 10–100 people (OR 1.89, 95% CI: 1.70 to 2.11; aOR 1.62, 95% CI: 1.42 to 1.85) and > 100 people (OR 2.33, 95% CI: 2.11 to 2.58; aOR 1.73, 95% CI: 1.53 to 1.97) were both associated with increased odds of COVID-19 infection. Handwashing before eating, avoiding touching the face, and cleaning things with virus on were all associated with increased odds of COVID-19 infections. Conclusions: This large observational study found evidence for strong protective effects for individuals from use of face coverings, social distancing (including avoiding crowded places) and handwashing on arriving home on developing COVID-19 infection. We also found evidence for an increased risk associated with other behaviours, possibly from recall bias